Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasms, Male × Gonadotropin-Releasing Hormone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 57 Breast Neoplasms 21 Neoplasms 5 Neoplasm Metastasis 3 Leiomyoma 3 Cardiovascular Diseases 3 Polycystic Ovary Syndrome 2 Neoplasms by Site 2 Endometrial Neoplasms 2 Breast Diseases 2 Stage II Prostate Adenocarcinoma 1 Sleep Wake Disorders 1 Skin Diseases 1 Salivary Gland Neoplasms 1 Salivary Gland Adenoma, Pleomorphic 1 Prostatic Neoplasms, Castration-Resistant 1 Prostatectomy 1 Prostate Cancer With ≤10 Bone Metastases 1 Prostate Cancer Metastatic Disease 1 Prostate Cancer Metastatic 1 Pelvic Pain 1 Ovarian Neoplasms 1 Osteoporosis 1 Oligometastatic Prostate Carcinoma 1 Obesity 1 Non-alcoholic Fatty Liver Disease 1 Metastatic Neuroendocrine Prostate Cancer 1 Metastatic Castration-resistant Prostate Cancer 1 Metastatic Castration-Resistant Prostate Cancer 1 Metabolic Syndrome 1

Interventions

Trastuzumab 27 Paclitaxel 26 Cyclophosphamide 26 Docetaxel 19 Taxes 17 Doxorubicin 17 Lapatinib 15 Radiotherapy 14 Capecitabine 12 Tamoxifen 11 Bevacizumab 11 Immunohistochemistry 9 Filgrastim 9 Carboplatin 9 Chemotherapy, Adjuvant 8 Biopsy 8 sargramostim 7 Granulocyte-Macrophage Colony-Stimulating Factor 7 Gemcitabine 7 Albumin-Bound Paclitaxel 7 pegfilgrastim 6 exemestane 6 Vorinostat 6 Magnetic Resonance Spectroscopy 6 Letrozole 6 Immunoenzyme Techniques 6 Goserelin 6 Everolimus 6 Anastrozole 6 ixabepilone 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01638247 2018-09-19

MALE

GBG Forschungs GmbH

Phase 3 Completed

Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon ⚡